IDEXX Laboratories Inc (IDXX)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Days Sales Outstanding (DSO) measures how efficiently a company collects its accounts receivable. A lower DSO indicates faster payment collection and better liquidity management. However, a consistently low DSO may suggest overly strict credit policies that could hinder sales growth.
For IDEXX Laboratories Inc, the provided data does not include specific DSO values but uses "—" to indicate missing or undisclosed information. Without actual DSO figures, it is challenging to assess the company's accounts receivable turnover efficiency or credit management practices.
To gain insights into IDEXX's financial health and operational efficiency regarding accounts receivable, it is necessary to obtain the DSO values for each reporting period to analyze trends over time. A trend analysis can help identify improvements or deterioration in the collection process and assess the effectiveness of the company's credit policies.
In conclusion, to provide a meaningful analysis of IDEXX's DSO, actual data points are needed to evaluate the company's ability to convert credit sales into cash and manage liquidity effectively.
Peer comparison
Dec 31, 2024